BACKGROUND: Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being higher in pooled buffy coat PC (BC-PC) than in apheresis units (AP-PC). Data about PC-induced alloimmunization against non-D Rhesus (Rh) antigens are limited. METHODS: For all newly detected RhD and non-D alloantibodies between August 2015 and September /2017 we prospectively evaluated if they were triggered through PC by analyzing for incompatible RBC and/or PC transfusions. RESULTS: We found 5,799 positive results in 89,190 antibody screening tests. We identified 13 newly detectable Rh antibodies through incompatible PCs in 11 patients: 6× anti-D, 4× anti-E, 2× anti-c, 1× anti-f. They received a total of 156 PC (83 BC-PC; 73 AP-PC): 5 patients received incompatible BC-PC only, 1 patient received incompatible AP-PC only, 5 patients received incompatible BC-PC and AP-PC. Quality control showed a mean (range) of 0.304 (0.152-1.662) and 0.014 (0.003-0.080) × 109 RBC/l for BC-PC and AP-PC, respectively. Ten of the 11 patients received RBC transfusions, all of them being antigen-negative for the alloantibodies identified. CONCLUSIONS: PC transfusions may not only induce RhD alloimmunization, but also immunization against further Rh antigens such as c, E, and f. The risk seems higher for BC-PC than for AP-PC. The results may have impact on future recommendations of PC transfusion with respect to Rh compatibility and upper limits of RBC contamination.
BACKGROUND: Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being higher in pooled buffy coat PC (BC-PC) than in apheresis units (AP-PC). Data about PC-induced alloimmunization against non-D Rhesus (Rh) antigens are limited. METHODS: For all newly detected RhD and non-D alloantibodies between August 2015 and September /2017 we prospectively evaluated if they were triggered through PC by analyzing for incompatible RBC and/or PC transfusions. RESULTS: We found 5,799 positive results in 89,190 antibody screening tests. We identified 13 newly detectable Rh antibodies through incompatible PCs in 11 patients: 6× anti-D, 4× anti-E, 2× anti-c, 1× anti-f. They received a total of 156 PC (83 BC-PC; 73 AP-PC): 5 patients received incompatible BC-PC only, 1 patient received incompatible AP-PC only, 5 patients received incompatible BC-PC and AP-PC. Quality control showed a mean (range) of 0.304 (0.152-1.662) and 0.014 (0.003-0.080) × 109 RBC/l for BC-PC and AP-PC, respectively. Ten of the 11 patients received RBC transfusions, all of them being antigen-negative for the alloantibodies identified. CONCLUSIONS: PC transfusions may not only induce RhD alloimmunization, but also immunization against further Rh antigens such as c, E, and f. The risk seems higher for BC-PC than for AP-PC. The results may have impact on future recommendations of PC transfusion with respect to Rh compatibility and upper limits of RBC contamination.
Authors: Henk Schonewille; Frans J C M Klumper; Leo M G van de Watering; Humphrey H H Kanhai; Anneke Brand Journal: Am J Obstet Gynecol Date: 2007-02 Impact factor: 8.661
Authors: Komal K Javarappa; Dimitrios Tsallos; Joseph Saad; Ujunwa Cynthia Okoye-Okafor; Daozheng Yang; Chi Zhang; Lumie Benard; Victor J Thiruthuvanathan; Sally Cole; Stephen Ruiz; Madhuri Tatiparthy; Gaurav Choudhary; Stefanie DeFronzo; Boris A Bartholdy; Celine Pallaud; Pedro Marques Ramos; Aditi Shastri; Amit Verma; Caroline A Heckman; Britta Will Journal: J Exp Med Date: 2022-09-02 Impact factor: 17.579
Authors: Louis Thibault; Marie Joëlle de Grandmont; Marie-Pierre Cayer; Nathalie Dussault; Annie Jacques; Eric Ducas; Annie Beauséjour; André Lebrun Journal: Transfus Med Hemother Date: 2019-06-27 Impact factor: 3.747
Authors: Chloe Cavagnetto; Richard Alejo Blanco; Hollie McKenna; Laura Willmott; Elif Aydogdu; Nicola Akinyemi; Helena Standring; Simon Procter; Johan W Lagerberg; Elin Johansson; Harry Croxon; Dirk de Korte; Stephen F Garner; Atsushi Shirakami; Jarob Saker; Joachim Linssen; Rebecca Cardigan Journal: Transfusion Date: 2020-11-17 Impact factor: 3.157